Hodgkin's lymphoma mortality in the Americas, 1997-2008: Achievements and persistent inadequacies

International Journal of Cancer

Volumn 133, Issue 3, 2013, Pages 687-694

  Chatenoud, Liliane ^a   Bertuccio, Paola ^a,b   Bosetti, Cristina ^a   Rodriguez, Teresa ^c   Levi, Fabio ^d   Negri, Eva ^a   Vecchia, Carlo La ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Servicio Navarro de Salud Osasunbidea Gerencia de Atención Primaria Subdirección de Urgencias de Navarra y Dirección Técnica de la Atención a la Urgencia Vital Navarra España   (Spain)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

cancer; Hodgkin's lymphoma; Latin America; mortality; trends

Indexed keywords

ADULT; ARGENTINA; ARTICLE; BIOSTATISTICS; BRAZIL; CANADA; CANCER MORTALITY; CANCER STATISTICS; CHILE; COLOMBIA; COMPARATIVE STUDY; COSTA RICA; CUBA; DATA BASE; ECUADOR; FEMALE; GUATEMALA; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEXICO; NORTH AMERICA; POPULATION RESEARCH; PRIORITY JOURNAL; UNITED STATES; VENEZUELA; WORLD HEALTH ORGANIZATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CENTRAL AMERICA; DACARBAZINE; DEVELOPING COUNTRIES; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MALE; NORTH AMERICA; SOUTH AMERICA; VINBLASTINE; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84877978500     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28049     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, cancer incidence and mortality worldwide. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr. Accessed on November 9, 2012.
2. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2009 (vintage 2009 populations). Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2009-pops09/. Accessed on November 9, 2012.
3. Devita VT, Jr, Serpick AA, Carbone PP,. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73: 881-95.
4. Santoro A, Bonadonna G, Valagussa P, et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 1987; 5: 27-37.
5. Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478-84.
6. Ansell SM, Armitage JO,. Management of Hodgkin lymphoma. Mayo Clin Proc 2006; 81: 419-26.
7. Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003; 348: 2386-95.
8. Flowers CR, Armitage JO,. A decade of progress in lymphoma: advances and continuing challenges. Clin Lymphoma Myeloma Leuk 2010; 10: 414-23.
9. Meyer RM, Gospodarowicz MK, Connors JM, et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. N Engl J Med 2012; 366: 399-408.
10. Bessell EM, Bouliotis G, Armstrong S, et al. Long-term survival after treatment for Hodgkin's disease (1973-2002): improved survival with successive 10-year cohorts. Br J Cancer 2012; 107: 531-6.
11. Levi F, Lucchini F, Negri E, et al. Trends in mortality from Hodgkin's disease in western and eastern Europe. Br J Cancer 2002; 87: 291-3.
12. Bosetti C, Levi F, Ferlay J, et al. The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe. Ann Oncol 2009; 20: 767-74.
13. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790-801.
14. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
15. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-36.
16. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian cancer statistics 2011. Available at: http://www.cancer.ca/canada-wide. aspx.sc.lang=en Toronto. Accessed May 2012.
17. Chatenoud L, Bertuccio P, Bosetti C, et al. Trends in cancer mortality in Brazil, 1980-2004. Eur J Cancer Prev 2010; 19: 79-86.
18. Bosetti C, Rodriguez T, Chatenoud L, et al. Trends in cancer mortality in Mexico, 1981-2007. Eur J Cancer Prev 2011; 20: 355-63.
19. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51; Erratum: Stat Med 2001;20:655.
20. World Health Organization Statistical Information System. WHO mortality database. Available at: http://www.who.int/whosis/mort/download/en/index.html. Accessed May 2012.
21. World Health Organization. WHO mortality database: Coverage and quality assessment of death registration data. Available at: http://www.who.int/ healthinfo/statistics/mortality/en/index.html. Accessed February 2013.
22. World Health Organization. International classification of disease, 9th edn. Geneva: World Health Organization, 1977.
23. World Health Organization. International statistical classification of disease and related health problems, 10th edn. Geneva: World Health Organization, 1992.
24. Pan American Health Organization (PAHO). Health statistics from the Americas, 2006. Chapter 6, 2-20. Available at: http://www.paho.org/English/DD/ AIS/HSA2006.htm. Accessed May 2012.
25. Pan American Health Organization (PAHO). Regional core health data initiative. Table generator system. Available at: http://www.paho.org/English/ SHA/coredata/tabulator/newTabulator.htm. Accessed May 2012.
26. Doll R, Smith PG,. Comparison between registries: age-standardized rates, vol. 4. In:, Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan S, eds. Cancer incidence in five continents. IARC Scientific Publications No. 42. Lyon, France: IARC, 1982. 671-75.
27. National Cancer Institute. Joinpoint regression program, version 3.5.2. Available at: http://srab.cancer.gov/joinpoint/. Accessed February 2012.
28. Clegg LX, Hankey BF, Tiwari R, et al. Estimating average annual percent change in trend analysis. Stat Med 2009; 28: 3670-82.
29. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. IARC Scientific Publications No. 160. Lyon, France: IARC, 2007. Available at: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/index. php. Accessed on November 9, 2012.
30. Boyle P,. Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res 1989; 114: 41-63.
31. Gil-Delgado MA, Khyat D, Johnson SAN,. Lymphomas. In:, Pollock RE, ed. UICC manual of clinical oncology, 8th edn. Hoboken, NJ: Wiley, 2004. Chapter 30, 671-89.
32. Percy C, Stanek E, III, Gloeckler L,. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71: 242-50.
33. Mathers CD, Boerma T, Ma Fat D,. Global and regional causes of death. Br Med Bull 2009; 92: 7-32.
34. Townsend W, Linch D,. Hodgkin's lymphoma in adults. Lancet 2012; 380: 836-47.
35. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-615.
36. Danaei G,. Global burden of infection-related cancer revisited. Lancet Oncol 2012; 13: 564-5.
37. Malvezzi M, Bosetti C, Chatenoud L, et al. Trends in cancer mortality in Mexico, 1970-1999. Ann Oncol 2004; 15: 1712-18.
38. Bertuccio P, Malvezzi M, Chatenoud L, et al. Testicular cancer mortality in the Americas, 1980-2003. Cancer 2007; 109: 776-9.
39. Fajardo-Gutierrez A, Sandoval-Mex AM, Mejia-Arangure JM, et al. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol 2002; 39: 25-31.
40. Torres Vigil I, Aday LA, De Lima L, et al. What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Symptom Manage 2007; 34: 315-27.
41. Barreto SM, Miranda JJ, Figueroa JP, et al. Epidemiology in Latin America and the Caribbean: current situation and challenges. Int J Epidemiol 2012; 41: 557-71.
42. Corrales G, Somoza Núñez R, Desenne Labonardier J, et al. Tratamiento de la enfermedad de Hodgkin, esquema MOPP/ABV. Rev Oncol 2002; 4: 378-84.
43. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008; 9: 721-9.
44. Garfield R, Santana S,. The impact of the economic crisis and the US embargo on health in Cuba. Am J Public Health 1997; 87: 15-20.
45. Drain PK, Barry M,. Global health. Fifty years of U.S. embargo: Cuba's health outcomes and lessons. Science 2010; 328: 572-3.